GL1X · GenesisL1 explorer

Research workbench

Impact of BRCA1 brct domain missense substitutions on phospho-peptide recognition: R1699Q

Analyse Impact of BRCA1 brct domain missense substitutions on phospho-peptide… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3PXC
Type
protein
Length
206 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Breast cancer type 1 susceptibility protein
EC
6.3.2.-
UniProt
P38398
Ligands
NI, SO4

Structure

x-ray diffraction · 1 distinct chain · 35% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
XBreast cancer type 1 susceptibility protein (EC 6.3.2.-)protein20635% helix, 19% strandP38398

Ligands and binding sites

  • NI · Nickel (II) ion · metal · chains X
  • SO4 · Sulfate ion · ion · chains X

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 3PXC · Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: R1699Q · the same entry in another collection · chain X against X, TM-score 1.00
  • P38398 · AlphaFold monomer V2.0 prediction for breast cancer type 1 susceptibility protein (P38398) · a predicted model of the same protein · chain X against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.